Literature DB >> 9380242

Studies on renal function in patients with cystinuria.

A Lindell1, T Denneberg, G Granerus.   

Abstract

Total and separate renal functions were evaluated in 40 patients with cystinuria. The average duration of the renal stone disease was 26 years (range 1-53). The patients had been subjected to a stone-preventing regimen composed of increased fluid intake, urinary alkalinization and treatment with a sulphydryl compound, tiopronin or D-penicillamine, for an average of 11.7 years (range 1-24). Urinary cystine concentration was determined regularly to monitor the treatment. All patients were examined with gamma camera renography and an assessment of glomerular filtration rate (GFR), and early and late renographic results could be compared in 30 patients. The early renographic evaluation showed that 43% of binephric patients (13/30) had an abnormal relative renal function (RRF) before the start of the stone-preventing treatment. At the late evaluation, 50% of binephric patients (17/34) had an abnormal RRF, while 30% of all patients (12/40) had a GFR below the age-related normal range. Thirty percent of 74 evaluated kidneys (22/74) had a separate GFR below an estimated age-related normal range. At the late evaluation only 30% of the patients had functionally unaffected kidneys with both normal GFR and bilateral normal renography. There was, however, no case with terminal renal failure. The separate GFR of kidneys with a history of staghorn stones was significantly lower than for kidneys without that special type of stones, but otherwise there was no relationship between renal functional impairment and other estimates of the activity of the renal stone disease. In conclusion, impairment of renal function is common in patients with stone-forming cystinuria. Stone-preventive treatment appears to be effective in preserving renal function. The high frequency of renal functional impairment justifies close surveillance of this group of patients. By renographic examination, unilateral changes in renal function can be detected at an early stage and patients at risk for further deterioration of renal function can be identified.

Entities:  

Mesh:

Year:  1997        PMID: 9380242     DOI: 10.1159/000190250

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

Review 1.  Stones: The dark side of stone disease - stones do still kill.

Authors:  Marcelino Rivera; Amy Krambeck
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

2.  CKD and Its Risk Factors among Patients with Cystinuria.

Authors:  Caroline Prot-Bertoye; Saïd Lebbah; Michel Daudon; Isabelle Tostivint; Pierre Bataille; Franck Bridoux; Pierre Brignon; Christian Choquenet; Pierre Cochat; Christian Combe; Pierre Conort; Stéphane Decramer; Bertrand Doré; Bertrand Dussol; Marie Essig; Nicolas Gaunez; Dominique Joly; Sophie Le Toquin-Bernard; Arnaud Méjean; Paul Meria; Denis Morin; Hung Viet N'Guyen; Christian Noël; Michel Normand; Michel Pietak; Pierre Ronco; Christian Saussine; Michel Tsimaratos; Gérard Friedlander; Olivier Traxer; Bertrand Knebelmann; Marie Courbebaisse
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-25       Impact factor: 8.237

3.  Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.

Authors:  Charles C Mikel; David S Goldfarb; Amy Ponte; Katherine Steigelman; Sergey Latyshev
Journal:  Urolithiasis       Date:  2022-10-06       Impact factor: 2.861

4.  Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children.

Authors:  Ralph J DeBerardinis; Curtis R Coughlin; Paige Kaplan
Journal:  J Urol       Date:  2008-10-31       Impact factor: 7.450

Review 5.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

6.  Cystine crystal volume determination: a useful tool in the management of cystinuric patients.

Authors:  Michel Daudon; Fabrice Cohen-Solal; Frédéric Barbey; Marie-France Gagnadoux; Bertrand Knebelmann; Paul Jungers
Journal:  Urol Res       Date:  2003-05-14

Review 7.  Do kidney stone formers have a kidney disease?

Authors:  Anna L Zisman; Andrew P Evan; Fredric L Coe; Elaine M Worcester
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.